Mutations in FN1 cause glomerulopathy with fibronectin deposits
Open Access
- 19 February 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (7), 2538-2543
- https://doi.org/10.1073/pnas.0707730105
Abstract
Glomerulopathy with fibronectin (FN) deposits (GFND) is an autosomal dominant disease with age-related penetrance, characterized by proteinuria, microscopic hematuria, hypertension, and massive glomerular deposits of FN that lead to end-stage renal failure. The genetic abnormality underlying GFND was still unknown. We hypothesized that mutations in FN1, which encodes FN, were the cause of GFND. In a large Italian pedigree with eight affected subjects, we found linkage with GFND at the FN1 locus at 2q32. We sequenced the FN1 in 15 unrelated pedigrees and found three heterozygous missense mutations, the W1925R, L1974R, and Y973C, that cosegregated with the disease in six pedigrees. The mutations affected two domains of FN (Hep-II domain for the W1925R and the L1974R, and Hep-III domain for the Y973C) that play key roles in FN-cell interaction and in FN fibrillogenesis. Mutant recombinant Hep-II fragments were expressed, and functional studies revealed a lower binding to heparin and to endothelial cells and podocytes compared with wild-type Hep-II and an impaired capability to induce endothelial cell spreading and cytoskeletal reorganization. Overall dominant mutations in FN1 accounted for 40% of cases of GFND in our study group. These findings may help understanding the pathogenesis of proteinuria and glomerular FN deposits in GFND and possibly in more common renal diseases such as diabetic nephropathy, IgA nephropathy, and lupus nephritis. To our knowledge no FN1 mutation causing a human disease was previously reported.Keywords
This publication has 36 references indexed in Scilit:
- The heparin III-binding domain of fibronectin (III4–5 repeats) binds to fibronectin and inhibits fibronectin matrix assemblyMatrix Biology, 2007
- The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native proteinClinical and Experimental Immunology, 2006
- Heparin II Domain of Fibronectin Uses α4β1 Integrin to Control Focal Adhesion and Stress Fiber Formation, Independent of Syndecan-4Published by Elsevier BV ,2005
- Mapping the Heparin-binding Site on the13–14F3 Fragment of FibronectinPublished by Elsevier BV ,2002
- Fibronectin glomerulopathy with nephrotic syndrome in a 3-year-old malePediatric Nephrology, 2002
- Alternative Splicing of the IIICS Domain in Fibronectin Governs the Role of the Heparin II Domain in Fibrillogenesis and Cell SpreadingPublished by Elsevier BV ,2002
- Molecular Cloning of the Critical Region for Glomerulopathy with Fibronectin Deposits (GFND) and Evaluation of Candidate GenesGenomics, 2000
- Glomerulopathy associated with predominant fibronectin deposits: Exclusion of the genes for fibronectin, villin and desmin as causative genesAmerican Journal of Medical Genetics, 1996
- Glomerulopathy associated with predominant fibronectin deposits: A newly recognized hereditary diseaseKidney International, 1995
- Fibronectin — Mediator between cells and connective tissueKlinische Wochenschrift, 1982